FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices
July 15 2021 - 4:51PM
Business Wire
- Clearance expands connectivity and interoperability of the
Dexcom CGM digital ecosystem
- Allows invited third-party developers to connect applications
and devices to real-time CGM data
- Gives Dexcom users more choice in where and how they interact
with their glucose data
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time
continuous glucose monitoring for people with diabetes, announced
today U.S. Food and Drug Administration (FDA) clearance of the
Dexcom Partner Web APIs, enabling invited third-party developers to
integrate real-time CGM data into their digital health apps and
devices.
“FDA clearance of our real-time APIs further solidifies Dexcom
as the leader in interoperable CGM, giving Dexcom users even more
choice in how they view and interact with their glucose data,” said
Jake Leach, chief technology officer at Dexcom. “The new APIs will
help seamlessly integrate the power of real-time Dexcom CGM data
into some of the leading diabetes and digital health
solutions.”
Several prominent diabetes and digital health companies have
been invited to access the real-time APIs and are already in the
testing and development phase, including Garmin® and Teladoc
Health’s Livongo® for Diabetes.
“Garmin welcomes the opportunity to bring Dexcom CGM data to
runners, cyclists and everyday users who rely on the technology
24/7 to proactively manage their diabetes,” said Joe Schrick, vice
president of fitness at Garmin. “We are proud to be part of this
integration that will allow users a secondary way to quickly and
discreetly view estimated glucose levels and trends right from
their smartwatch at any time.”
People with diabetes and their healthcare providers will benefit
from the integration of real-time Dexcom CGM data into third-party
apps and devices in a multitude of ways. For example, it will:
- Allow users to quickly see all their therapy data in one
place
- Empower users to utilize the apps they find most beneficial for
a more tailored Dexcom experience
- Enable in-the-moment diabetes management coaching and
feedback
For more information about the Dexcom real-time APIs and other
offerings for third-party developers, visit Dexcom.com/WebAPI.
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom simplifies and improves
diabetes management around the world. For more information about
Dexcom CGM, visit www.dexcom.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210715006049/en/
Media Contact: James McIntosh, (619) 884-2118 Dexcom
Public Relations james.mcintosh@dexcom.com Investor Contact:
Sean Christensen, (858) 203-6657 Dexcom Corporate Affairs
sean.christensen@dexcom.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jun 2024 to Jul 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jul 2023 to Jul 2024